Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.

Krusenstjerna-Hafstrøm T, Clasen BF, Møller N, Jessen N, Pedersen SB, Christiansen JS, Jørgensen JO.

J Clin Endocrinol Metab. 2011 Aug;96(8):2548-57. doi: 10.1210/jc.2011-0273. Epub 2011 May 25.

PMID:
21613350
2.

Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men.

Krusenstjerna-Hafstrøm T, Vestergaard ET, Buhl M, Nielsen R, Clasen BF, Nielsen S, Møller N, Pedersen SB, Jørgensen JO.

J Clin Endocrinol Metab. 2011 Aug;96(8):2581-9. doi: 10.1210/jc.2011-0592. Epub 2011 Jun 1.

PMID:
21632809
3.

Glucose flux is normalized by compensatory hyperinsulinaemia in growth hormone-induced insulin resistance in healthy subjects, while skeletal muscle protein synthesis remains unchanged.

Nygren J, Thorell A, Brismar K, Essén P, Wernerman J, McNurlan MA, Garlick PJ, Ljungqvist O.

Clin Sci (Lond). 2002 Apr;102(4):457-64.

PMID:
11914108
4.

Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.

Jessen N, Djurhuus CB, Jørgensen JO, Jensen LS, Møller N, Lund S, Schmitz O.

Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E194-9. Epub 2004 Aug 31.

PMID:
15339744
5.

Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.

Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Møller N, Lund S, Jørgensen JO.

J Clin Endocrinol Metab. 2008 Jul;93(7):2842-50. doi: 10.1210/jc.2007-2414. Epub 2008 May 6.

PMID:
18460563
6.

Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency.

Yuen KC, Roberts CT Jr, Frystyk J, Rooney WD, Pollaro JR, Klopfenstein BJ, Purnell JQ.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1862-9. doi: 10.1210/jc.2014-1532. Epub 2014 Jul 11.

7.

Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.

Storgaard H, Jensen CB, Björnholm M, Song XM, Madsbad S, Zierath JR, Vaag AA.

J Clin Endocrinol Metab. 2004 Mar;89(3):1301-11.

PMID:
15001626
8.
9.

Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.

Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L.

J Clin Endocrinol Metab. 2003 Apr;88(4):1455-63.

PMID:
12679422
10.

Impact of fasting on growth hormone signaling and action in muscle and fat.

Moller L, Dalman L, Norrelund H, Billestrup N, Frystyk J, Moller N, Jorgensen JO.

J Clin Endocrinol Metab. 2009 Mar;94(3):965-72. doi: 10.1210/jc.2008-1385. Epub 2008 Dec 9.

PMID:
19066303
11.

Acute effects of ghrelin administration on glucose and lipid metabolism.

Vestergaard ET, Djurhuus CB, Gjedsted J, Nielsen S, Møller N, Holst JJ, Jørgensen JO, Schmitz O.

J Clin Endocrinol Metab. 2008 Feb;93(2):438-44. Epub 2007 Nov 27.

PMID:
18042651
12.

Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.

Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.

Eur J Endocrinol. 2003 Dec;149(6):511-9.

13.

Effects of morning cortisol replacement on glucose and lipid metabolism in GH-treated subjects.

Segerlantz M, Bramnert M, Thomasson R, Manhem P, Laurila E, Groop LC.

Eur J Endocrinol. 2004 Dec;151(6):701-7.

14.

Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.

Bianda TL, Hussain MA, Keller A, Glatz Y, Schmitz O, Christiansen JS, Alberti KG, Froesch ER.

Diabetologia. 1996 Aug;39(8):961-9.

PMID:
8858219
15.

Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.

Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, Froesch ER.

J Clin Invest. 1994 Sep;94(3):1126-33.

16.

Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects.

Moller L, Norrelund H, Jessen N, Flyvbjerg A, Pedersen SB, Gaylinn BD, Liu J, Thorner MO, Moller N, Lunde Jorgensen JO.

J Clin Endocrinol Metab. 2009 Nov;94(11):4524-32. doi: 10.1210/jc.2009-0381. Epub 2009 Oct 9.

17.

Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.

Damjanovic SS, Lalic NM, Pesko PM, Petakov MS, Jotic A, Miljic D, Lalic KS, Lukic L, Djurovic M, Djukic VB.

J Clin Endocrinol Metab. 2006 Jul;91(7):2574-81. Epub 2006 Apr 18.

PMID:
16621911
18.

Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.

PMID:
12006367
19.

Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.

Diabetes. 2003 Aug;52(8):1943-50.

20.

Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men.

Kanaley JA, Dall R, Møller N, Nielsen SC, Christiansen JS, Jensen MD, Jørgensen JO.

J Appl Physiol (1985). 2004 Feb;96(2):747-53. Epub 2003 Oct 31.

PMID:
14594860

Supplemental Content

Support Center